• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S.

    8/31/23 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care
    Get the next $UTMD alert in real time by email

    SALT LAKE CITY, UT / ACCESSWIRE / August 31, 2023 / As Utah Medical Products, Inc.'s (NASDAQ:UTMD) stockholders know, the following disclosure was included in the Company's 2022 SEC 10-K annual report, released in March 2023:

    "In late 2021, after the Filshie clip had been used in the U.S. for 25 years and implanted in millions of women, a clip migration lawsuit was filed in Texas. Subsequently, the same law firm solicited and recruited claimants in other states. As of the end of January 2023, there were a total of fourteen clip migration lawsuits initiated by the same law firm in twelve different states. UTMD has filed motions to dismiss in most of those lawsuits, one of which has been granted. A dismissal can be appealed, but as of yet hasn't been. Management expects others to be dismissed based on legal grounds such as lack of jurisdiction or U.S. FDA preemption."

    UTMD now provides an update on the status and progress of these lawsuits. There were 71 total claimants represented in the fourteen lawsuits referenced above. All of the lawsuits except one were filed in federal courts. The exception was a lawsuit with 50 claimants filed in Utah (UT) State court. The thirteen other lawsuits were comprised of a total 21 claimants. On August 29, the UT state court dismissed the UT complaint with prejudice. Three of the original thirteen federal lawsuits have also been dismissed to date.

    However, since the above disclosure, plaintiff law firm has continued to solicit for claimants through social media, and filed additional lawsuits with pleadings substantially the same in all. The court opinions supporting dismissal have been provided as supplemental authority to the other courts with open dismissal motions.

    Two additional federal lawsuits and one additional state lawsuit have been filed since the SEC 10-K disclosure. One of the additional federal lawsuits in New York has already been dismissed, for a total of five dismissals. The additional state lawsuit was filed in Connecticut (CT), originally in April with 10 new claimants. The CT lawsuit has been twice updated adding new claimants, most recently this week. The CT lawsuit now has 43 new claimants (and three other claimants whose federal lawsuits were previously dismissed and who have re-filed in CT).

    In summary, as of this date, seventeen lawsuits have been filed in fourteen states, with a total of 117 claimants. All except two lawsuits were filed in federal courts. The two state lawsuits were filed in UT and CT, the domiciles of UTMD and CooperSurgical, Inc, respectively. None of the lawsuits have gone to trial yet, and several have motions to dismiss still pending.

    As of this date, five lawsuits comprised of fifty-four claimants have been dismissed. There remain twelve lawsuits in eleven states comprised of sixty-three new claimants.

    Number Originally FiledNumber Currently Remaining Open
    No. of Lawsuits

    17

    12

    No. of States

    14

    11

    No. of Claimants

    117

    63

    According to CEO Kevin Cornwell,

    "UTMD remains committed to defending the decades-long reputation of the Filshie clip System for its excellent safety and effectiveness. We are pleased with our recent victories and look forward to continued success in defeating these meritless claims."

    Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.

    CONTACT:
    Brian Koopman
    (801) 566-1200

    SOURCE: Utah Medical Products, Inc.



    View source version on accesswire.com:
    https://www.accesswire.com/778800/utmd-updates-status-of-filshie-product-liability-lawsuits-in-the-us

    Get the next $UTMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UTMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $UTMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Leigh Carrie claimed ownership of 51 shares (SEC Form 3)

    3 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)

    11/12/24 9:51:55 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Principal Financial Officer Koopman Brian

    4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)

    11/8/24 11:58:20 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Principal Financial Officer Koopman Brian gifted 50 shares, decreasing direct ownership by 5% to 882 units (SEC Form 4)

    4 - UTAH MEDICAL PRODUCTS INC (0000706698) (Issuer)

    7/22/24 4:56:33 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last position as UTMD's manager of Global Direct End User Sales, the Board believes her robust understanding of the functional and strategic challenges that the Company faces will be integral for achieving future revenue growth.In addition, the Board of Directors appr

    11/5/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

    SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom line, compared to its beginning of year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.Overview of ResultsThe following is a summary comparison of 3Q and 9M of calendar 2024 with 3Q and 9M 2023 income statement mea

    10/29/24 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Utah Medical Products, Inc. Announces Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtain

    8/2/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    SEC Filings

    View All

    SEC Form 10-Q filed by Utah Medical Products Inc.

    10-Q - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)

    8/12/25 3:51:42 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Utah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UTAH MEDICAL PRODUCTS INC (0000706698) (Filer)

    7/24/25 2:03:58 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Utah Medical Products Inc.

    SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    7/15/25 4:03:17 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Leadership Updates

    Live Leadership Updates

    View All

    Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last position as UTMD's manager of Global Direct End User Sales, the Board believes her robust understanding of the functional and strategic challenges that the Company faces will be integral for achieving future revenue growth.In addition, the Board of Directors appr

    11/5/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Utah Medical Products Inc.

    SC 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    11/12/24 6:02:32 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Utah Medical Products Inc.

    SC 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    11/12/24 10:34:17 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Utah Medical Products Inc.

    SC 13G/A - UTAH MEDICAL PRODUCTS INC (0000706698) (Subject)

    11/4/24 2:00:49 PM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    $UTMD
    Financials

    Live finance-specific insights

    View All

    UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

    SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom line, compared to its beginning of year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.Overview of ResultsThe following is a summary comparison of 3Q and 9M of calendar 2024 with 3Q and 9M 2023 income statement mea

    10/29/24 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    Utah Medical Products, Inc. Announces Quarterly Dividend

    SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtain

    8/2/24 10:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care

    UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024

    SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (NASDAQ:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results which reflect a substantial decline in revenues.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. Because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results

    7/25/24 9:00:00 AM ET
    $UTMD
    Medical/Dental Instruments
    Health Care